| Trial ID: | L2703 |
| Source ID: | NCT00788840
|
| Associated Drug: |
Insulatard
|
| Title: |
Detemir Energy Expenditure Study
|
| Acronym: |
DEES
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus|Obesity
|
| Interventions: |
DRUG: Insulatard|DRUG: Detemir
|
| Outcome Measures: |
Primary: Weight change, 6 months | Secondary: Energy Expenditure, 6 months|Fat composition, 6 months|Fat & muscle gene expression, 6 months|Glycaemic control, 6 months
|
| Sponsor/Collaborators: |
Sponsor: University of Surrey | Collaborators: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
30
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2008-01
|
| Completion Date: |
2009-08
|
| Results First Posted: |
|
| Last Update Posted: |
2023-05-31
|
| Locations: |
Cedar Centre, Royal Surrey County Hospital, Guildford, Surrey, GU2 7XX, United Kingdom
|
| URL: |
https://clinicaltrials.gov/show/NCT00788840
|
